PATENT CLAIM ANALYSIS

Application Number: 16032025
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "501000"]

Abstract:
A pharmaceutical dosage form which comprises a lactide, glycolide or lactide-glycolide polymer, a block polymer of polyglycolide, trimethylene carbonate, poly-caprolactone, and polyethylene oxide that is combined with a peptide or protein therapeutic agent in the form of microparticles which are compressed using a pressure of 50,000 to 350,000 psi.

Claim (Index 1):
A pharmaceutical dosage form which comprises a lactide, glycolide or lactide-glycolide polymer, a block polymer of polyglycolide and trimethylene carbonate or a block polymer of poly-caprolactone and trimethylene carbonate or polyethylene oxide that is combined with a peptide or protein therapeutic agent in the form of microparticles which are compressed using a pressure of 50,000 to 350,000 psi.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 95.0
- Lexical Diversity: 1.30952
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16031665', '12386853', '14124631', '14037528', '09687951']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7565478741277385
- 35 USC 102 Novelty (BERT): 0.5257628326219861
- Combined Prediction Score: 0.7334693699771633
- Mean Citation Score: 243.73186
- Max Citation Score: 330.1318
- Similarity Product: 250.08735095790627

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test